Background & Aims: Racial disparities have been reported in liver transplantation and chronic hepatitis C treatment outcomes. Determining causes of these disparities is important given the racially diverse American population and the economic burden associated with chronic liver disease.
Methods: A retrospective study was performed among 463 patients diagnosed with cirrhosis admitted from (January 1, 2013 to January 1, 2018) to a tertiary care academic medical center. Patients were identified based on the International Classification of Diseases (ICD-10) for cirrhosis or its complications. Demographic information, laboratory data, medical comorbidities, insurance and adherence to cirrhosis quality care indicators were recorded to determine their relationship to readmission rates and other healthcare outcomes.
Results: A total of 463 individual patients with cirrhosis were identified including Whites (n=241), Hispanics (n=106), Blacks (n=50), Asian and Pacific Islander Americans (API, n=27) and Other (n=39). A significantly higher proportion of Blacks had Medicaid insurance compared to Whites (40% versus 20%, p=0.0002) and Blacks had lower median income than Whites ($45,710 versus $54,844, p=0.01). All groups received high quality cirrhosis care. Regarding healthcare outcomes, Black patients had the highest mean total hospital admissions (6.1±6.3, p=0.01) and the highest mean number of 30-day re-admissions (2.1±3.7, p=0.05) compared to all other racial groups. Multivariable proportional odds regression analysis showed that race was a statistically significant predictor of 90-day readmission (p=0.03).
Conclusions: Black Americans hospitalized for complications of cirrhosis may experience significant disparities in healthcare outcomes compared to whites despite high quality cirrhosis care. Socioeconomic factors may contribute to these disparities.